One Month in for Trump Administration II: What Do We Know About the FDA?

Part Two: One Month in for Trump Administration II: What Do We Know About the FDA?

With RFK Jr.’s confirmation hearings in process, we are keeping our fingers on the pulse. Polsinelli’s seasoned FDA practitioners and special guest, Wayne Pines, will be re-convening for part two of our webinar series to discuss the first month of the second Trump Administration, and what we know about the FDA so far.

Agenda

• Trump Administration's Push for Federal Employees to Resign: Implications for FDA & Stakeholders
• Likely Impacts of Return to In-Person Work Executive Order
• Anti-DEI Initiatives and Implications for Clinical Trial Diversity
• Might FDA Decisions Become More Influenced by Politics? What to Do if That Happens